Evidence map›Paper›PMID 40275004›Full record

ArticleScientific reports2025

Optimizing feasibility and reproducibility of pacing-induced heart failure model in pigs.

Jaakko Lampela, Niko Järveläinen, Anni Määttä, Satu Siimes, Minja Heikkilä, Hanna Wang, Jarkko Kuivalainen, Juho Liljeström, Ville Vepsäläinen, Juha Hartikainen and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Gene Therapy for Heart Failure.Journal of cardiovascular translational research · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jaakko LampelaA.I. Virtanen Institute for Molecular sciences, University of Eastern Finland, Kuopio, Finland.
Niko JärveläinenA.I. Virtanen Institute for Molecular sciences, University of Eastern Finland, Kuopio, Finland.
Anni MäättäA.I. Virtanen Institute for Molecular sciences, University of Eastern Finland, Kuopio, Finland.
Satu SiimesA.I. Virtanen Institute for Molecular sciences, University of Eastern Finland, Kuopio, Finland.
Minja HeikkiläA.I. Virtanen Institute for Molecular sciences, University of Eastern Finland, Kuopio, Finland.
Hanna WangA.I. Virtanen Institute for Molecular sciences, University of Eastern Finland, Kuopio, Finland.
Jarkko KuivalainenA.I. Virtanen Institute for Molecular sciences, University of Eastern Finland, Kuopio, Finland.
Juho LiljeströmA.I. Virtanen Institute for Molecular sciences, University of Eastern Finland, Kuopio, Finland.
Ville VepsäläinenHeart Center, Kuopio University Hospital, Kuopio, Finland.
Juha HartikainenHeart Center, Kuopio University Hospital, Kuopio, Finland.
Seppo Ylä-HerttualaA.I. Virtanen Institute for Molecular sciences, University of Eastern Finland, Kuopio, Finland. seppo.ylaherttuala@uef.fi.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heart failure (HF) is a major health problem worldwide, where gene therapy could provide promising new approaches for effective treatments. Pacing-induced tachycardiomyopathy in large animals is a well-established HF model but it suffers from poor tolerability and variable outcomes. In this study, we developed a reproducible, feasible, and tolerable pacing protocol for HF gene therapy studies. Single-chamber pacemakers were implanted in pigs. HF development was monitored with trans-thoracic echocardiography (TTE), invasive left-ventricular (LV) pressure measurements, and a treadmill exercise stress test. Four weeks of rapid right-ventricular pacing at over 200 bpm produced a significant impairment of cardiac function (LV stroke volume index 11.8 ± 1.22 (mL/m

Indexed as

Cardiac Pacing, ArtificialHeart FailureAnimalsDisease Models, AnimalEchocardiographyExercise TestFeasibility StudiesPacemaker, ArtificialReproducibility of ResultsSwine

Identifiers

PMID40275004
PMCPMC12022008

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.